Cetera Investment Advisers decreased its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 3.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 232,855 shares of the real estate investment trust’s stock after selling 7,104 shares during the quarter. Cetera Investment Advisers’ holdings in Healthpeak Properties were worth $4,077,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Fifth Third Wealth Advisors LLC boosted its holdings in shares of Healthpeak Properties by 2.4% during the 2nd quarter. Fifth Third Wealth Advisors LLC now owns 22,811 shares of the real estate investment trust’s stock worth $399,000 after buying an additional 543 shares during the period. LRI Investments LLC lifted its position in Healthpeak Properties by 18.4% during the second quarter. LRI Investments LLC now owns 4,481 shares of the real estate investment trust’s stock worth $78,000 after acquiring an additional 697 shares during the last quarter. Banco Bilbao Vizcaya Argentaria S.A. boosted its holdings in shares of Healthpeak Properties by 4.1% during the first quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 18,146 shares of the real estate investment trust’s stock worth $367,000 after acquiring an additional 722 shares during the period. CX Institutional grew its position in shares of Healthpeak Properties by 11.9% in the second quarter. CX Institutional now owns 6,820 shares of the real estate investment trust’s stock valued at $119,000 after purchasing an additional 726 shares during the last quarter. Finally, TCTC Holdings LLC increased its stake in shares of Healthpeak Properties by 124.3% during the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 751 shares during the period. 93.57% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several analysts recently issued reports on the company. Morgan Stanley reduced their price target on Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a research note on Friday, August 22nd. Evercore ISI set a $22.00 target price on shares of Healthpeak Properties in a research report on Monday, September 15th. Cantor Fitzgerald assumed coverage on shares of Healthpeak Properties in a research report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price target on the stock. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $18.00 price target (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Finally, Robert W. Baird reduced their price target on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 12th. Seven analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and an average target price of $20.91.
Healthpeak Properties Price Performance
Shares of DOC stock opened at $18.12 on Wednesday. The business has a fifty day simple moving average of $18.28 and a 200 day simple moving average of $17.84. The company has a market cap of $12.59 billion, a P/E ratio of -362.23, a P/E/G ratio of 3.84 and a beta of 1.10. The company has a quick ratio of 1.28, a current ratio of 1.22 and a debt-to-equity ratio of 1.11. Healthpeak Properties, Inc. has a twelve month low of $16.63 and a twelve month high of $22.71.
Healthpeak Properties (NYSE:DOC – Get Free Report) last issued its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 EPS for the quarter, topping the consensus estimate of $0.45 by $0.01. The firm had revenue of $705.87 million during the quarter, compared to the consensus estimate of $681.65 million. Healthpeak Properties had a negative return on equity of 0.44% and a negative net margin of 1.36%.The business’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.
Healthpeak Properties Announces Dividend
The business also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Friday, December 19th. This represents a c) annualized dividend and a yield of 6.7%. Healthpeak Properties’s dividend payout ratio is presently -2,440.00%.
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
- Five stocks we like better than Healthpeak Properties
- How to Calculate Options Profits
- Warner Bros. Sale Rumors Heat Up: What Investors Need to Know
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- From Science Project to Solvent: WeRide’s 761% Revenue Surge
- How to Plot Fibonacci Price Inflection Levels
- Will the S&P 500 Rally in December? These 3 Signals Point to a Big Move Ahead
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
